November 30th 2023
The experts weighed in on a wide variety of psychiatric issues for the November 2023 issue of Psychiatric Times.
November 25th 2023
From late-life treatment-resistant depression to the mental health benefits of gratitude, here are highlights from the week in Psychiatric Times.
November 21st 2023
In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.
November 14th 2023
Young men appear to be particularly susceptible to the effects of cannabis on schizophrenia.
November 3rd 2023
What is new in research on SUDs?
Medical Marijuana for Autism
Cannabis is prescribed as a treatment for autism in 14 states. Is it the wonder drug patients and families have been waiting for?
The Trip Resumes for Psychedelics, Psychiatry, and Society
There's a long history of psychedelics...
What About Us? The Marginalization of Serious Mental Health and Substance Use
How can mental health professionals promote a true community of immunity?
Confronting the Methamphetamine Epidemic
As all eyes were on the pandemic, another surge simmered below the surface.
A Tale of Two Crises: Fighting the Overdose Problem During the Pandemic
According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?
Clearing the Smoke: FDA Working Toward Tobacco Flavor Ban to Save Lives, Promote Health Equity
Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.
Exploring the Link Between Neuroticism-Depression and College Drinking
Although college drinking develops into an addiction, overconsumption and especially binge drinking patterns are often preludes to alcohol use disorder, with approximately 1 in 10 students meeting criteria for AUD.
Could Artificial Intelligence Improve Cognitive Behavioral Therapy?
A recent study tested a new digital therapeutic for effectiveness on both substance abuse and depression.
Biden Administration Plan Tackles Drug Addiction Crisis
Government funding for the drug addiction crisis is on the way.
You Spoke, We Listened. Psychiatry's Cannabis Survey
Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.
Cannabis 2021: What Clinicians Need to Know
The sharply decreasing perception of risk and easy accessibility of cannabis has many patients turning towards it, despite the potential negative effects.
FDA Says: No Approval, No Label, No Service
As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.
Does Cannabis Cause Psychosis?
A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.
Clinician, Patients Take the Fight for Psilocybin To Court
Should a patient at the end of her life have access to psilocybin, even if it’s illegal?
A Young Man Presents With Perplexing Symptoms: What Is Going on Here?
Psychiatrists face diagnostic puzzles almost every day. Find out how one clinician cracked a tough case.
Addressing Smoking: Is Varenicline the Answer?
Many patients with bipolar and other psychiatric disorders believe it is better to wait to address cigarette and other nicotine use. Here is why that is not necessarily the case.
The Cardiovascular Consequences of Drug Use
Some commonly used drugs and narcotics have serious cardiovascular effects.
Race and Opioids: Lessons From the Civil War-Era Opioid Addiction Crisis
Black soldiers’ lack of access to opiate analgesics and antidiarrheals was typical, not exceptional, when considered within the broader scheme of Civil War medicine.
Effectively Treating Opioid Use Disorder
What digital therapeutic treatment for opioid use disorder will soon be available to complement psychiatric care?
Pain and Smoking: Is There an Association?
Two recent papers look at the subtle and surprising links between smoking and pain in different parts of the body.
Cannabis-Based Medicine Without the Addiction Risks?
Research on a new kind of cannabis treatment prepares to move forward.
Neuroticism-Depression: What Is It and Does It Play a Role in College Drinking?
Are people with high "neuroticism-depression" likely to drink more than the average person when stressed? We may be getting closer to the answer.
Cannabis & Significant Effects on the Wiring of the Brain
Look at the big picture on cannabis: what harmful effects could it potentially have on your patients' brains?
Treating Trauma and Addiction Simultaneously
1 in 6 people with opioid use disorder experience a new traumatic event every month, but no evidence-based treatment for trauma.
Poll: Prescribing Cannabis
What are your thoughts about prescribing medical marijuana/cannabis to treat psychiatric disorders?
Professional Opinion: Cannabis
What are your feelings about the utility of cannabis in psychiatric practice?
Improving Care in Teens With Opioid Use Disorder
With opioid use disorder, a tiny fraction of young patients are getting treatment, which would not be acceptable for any other medical condition.
Dropping the X-Waiver for Buprenorphine
The Department of Health and Human Services moves to reduce administrative procedural barriers to OUD treatment.
Medicine Combination With the Potential to Beat Methamphetamine Use Disorder
In an ADAPT-2 study, a combination of injectable naltrexone and oral bupropion showed promise for methamphetamine users.
After COVID-19 and Beyond the Opioid Wave
Lessons from the opioid epidemic should be applied to cases of methamphetamine abuse.
2 Clarke Drive Cranbury, NJ 08512